SIRIO(SZ:300791) Zheng Quan Shi Bao Wang·2025-08-20 10:21Core Insights - The pet health consumption market is entering a phase of rapid growth characterized by "quality upgrades and functionalization," presenting significant market opportunities [1] - The company is actively positioning itself in the pet health sector, targeting a market size of 100 billion [1] Industry Trends - The pet consumption scale has been expanding, with increasing entrants in the pet industry and a focus on building a complete pet industry chain at the local economic development level [2] - There is a notable shift in consumer demand from basic safety and nutrition to the natural quality of ingredients and scientific nutrition [4] - The demand for personalized nutrition is rising, with pet owners seeking tailored formulas based on their pets' breed, age, and health status [5] Company Strategy - The company aims to leverage its expertise in human nutrition to develop differentiated pet products, focusing on three main R&D directions: species-specific nutrition systems, application of formulation enhancement technologies, and intelligent palatability solutions [6] - A recent product, "NUTRIFUSE super-soluble krill fish oil," demonstrates the company's ability to innovate by improving absorption efficiency and flavor, achieving a 91% preference rate among cats [6] Competitive Advantage - The company's core competencies include precise solution capabilities driven by deep market insights, strong R&D barriers supported by technological accumulation, and collaborative synergies from its customer network [8] - The company has established a specialized research system covering eight functional areas, enabling it to quickly address unmet needs in pet health [8] Market Potential - The domestic pet consumption reached 77.375 billion in the first half of 2025, with a year-on-year growth of 8.84%, indicating substantial growth potential in the pet health market [9] - The pet ownership rate in China is approximately 20%, significantly lower than the nearly 70% in the U.S., suggesting considerable room for growth [9] - The company plans to leverage its Shantou pet factory to quickly launch a differentiated product matrix and aims to create long-term competitive advantages in the pet health sector [9]